RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CLDX
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Celldex Therapeutics stock price down 2.97% on Wednesday
(Updated on Jul 03, 2024)

Sell candidate since Jul 02, 2024 Loss -2.97% PDF

The Celldex Therapeutics stock price fell by -2.97% on the last day (Wednesday, 3rd Jul 2024) from $37.01 to $35.91. During the last trading day the stock fluctuated 4.20% from a day low at $35.91 to a day high of $37.42. The price has been going up and down for this period, and there has been a 3.61% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -446 thousand shares and in total, 207 thousand shares were bought and sold for approximately $7.43 million.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -11.31% during the next 3 months and, with a 90% probability hold a price between $27.64 and $34.44 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CLDX Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Celldex Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $36.99 and $36.10. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, July 01, 2024, and so far it has fallen -7.90%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Celldex Therapeutics stock

Celldex Therapeutics finds support from accumulated volume at $35.38 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.51 between high and low, or 4.20%. For the last week, the stock has had daily average volatility of 5.71%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CLDX) For The Upcoming Trading Day Of Friday 5th

For the upcoming trading day on Friday, 5th we expect Celldex Therapeutics to open at $36.41, and during the day (based on 14 day Average True Range), to move between $34.28 and $37.54, which gives a possible trading interval of +/-$1.63 (+/-4.53%) up or down from last closing price. If Celldex Therapeutics takes out the full calculated possible swing range there will be an estimated 9.05% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $36.26 (0.97%) than the support at $35.38 (1.48%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Celldex Therapeutics stock A Buy?

Celldex Therapeutics holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.021 Sell Candidate Unchanged

Predicted Opening Price for Celldex Therapeutics of Friday, July 5, 2024

Fair opening price July 5, 2024 Current price
$36.41 ( 1.40%) $35.91

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CLDX

Fibonacci Support & Resistance Levels

Level Price
R3 37.92 5.61%
R2 37.35 4.00%
R1 36.99 3.01%
Price 35.91
S1 35.84 -0.205%
S2 35.48 -1.20%
S3 34.90 -2.80%

Accumulated Volume Support & Resistance Levels

Level Price
R3 42.21 17.54%
R2 37.01 3.06%
R1 36.26 0.97%
Price 35.91
S1 35.38 -1.48%
S2 35.27 -1.78%
S3 32.76 -8.77%

FAQ

What is the symbol for Celldex Therapeutics Stock and on which exchange is it traded?
The symbol for Celldex Therapeutics is CLDX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Celldex Therapeutics Stock?
Celldex Therapeutics holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Celldex Therapeutics Stock?
Celldex Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Celldex Therapeutics Stock.

What's the current price of Celldex Therapeutics Stock?
As of the end of day on the Jul 03, 2024, the price of an Celldex Therapeutics (CLDX) share was $35.91.

What is the 52-week high and low for Celldex Therapeutics Stock?
The 52-week high for Celldex Therapeutics Stock is $53.18 and the 52-week low is $22.11.

What is the market capitalization of Celldex Therapeutics Stock?
As of the Jul 03, 2024, the market capitalization of Celldex Therapeutics is 2.367B.

When is the next earnings date for Celldex Therapeutics?
The upcoming earnings date for Celldex Therapeutics is Aug 13, 2024.
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT